Ainos, Inc.
General ticker "AIMD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.8M (TTM average)
Ainos, Inc. follows the US Stock Market performance with the rate: 28.6%.
Estimated limits based on current volatility of 5.2%: low 2.21$, high 2.45$
Factors to consider:
- Total employees count: 46 as of 2023
- Top business risk factors: Operating losses, Economic downturns and volatility, Product development delays, Regulatory and compliance, Strategic risks and growth management
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.70$, 5.34$]
- 2025-12-31 to 2026-12-31 estimated range: [1.42$, 4.49$]
Financial Metrics affecting the AIMD estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -26.64 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 53.84 <= 63.39
- Positive: Investing cash flow per share per price, % of -0.57 > -0.66
- Positive: Interest expense per share per price, % of 2.83 <= 3.41
Short-term AIMD quotes
Long-term AIMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3.52MM | $0.12MM | $0.02MM |
| Operating Expenses | $17.50MM | $13.33MM | $13.86MM |
| Operating Income | $-13.98MM | $-13.21MM | $-13.84MM |
| Non-Operating Income | $-0.03MM | $-0.56MM | $-1.02MM |
| Interest Expense | $0.05MM | $0.14MM | $0.62MM |
| R&D Expense | $6.85MM | $7.32MM | $8.41MM |
| Income(Loss) | $-14.01MM | $-13.77MM | $-14.86MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-14.01MM | $-13.77MM | $-14.86MM |
| Stockholders Equity | $34.63MM | $24.45MM | $15.52MM |
| Inventory | $0.60MM | $0.17MM | $0.14MM |
| Assets | $37.11MM | $31.84MM | $28.82MM |
| Operating Cash Flow | $-3.04MM | $-4.69MM | $-5.81MM |
| Capital expenditure | $0.63MM | $0.09MM | $0.02MM |
| Investing Cash Flow | $-0.63MM | $-0.10MM | $-0.13MM |
| Financing Cash Flow | $3.85MM | $4.92MM | $8.03MM |
| Earnings Per Share** | $-5.14 | $-3.36 | $-1.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.